Project Details
Abstract
Evidence continues to mount that aneuploidy is a contributing factor in tumor development,
and that aneuploidy may serve as a target for anti-cancer therapy. Initial hypotheses posited
that cancer cells have a destroyed spindle checkpoint pathway. However, the spindle
checkpoint has been observed to be essential even in cancer cells. There are numerous ways
the spindle checkpoint can be damaged, and two established mechanisms that occur in vivo
are either by mutating core checkpoint components, or by generating an imbalance in the
Mad1:Mad2 ratio, which are two core checkpoint proteins that form a hetero-tetrameric
complex. The ratio of Mad1:Mad2 has been manipulated in several organisms and these
manipulations lead to aberrant checkpoint function, chromosome loss, and promoted
tumorigenesis in animal models. In Aim 1, I propose to use the in vitro system to investigate
aberrant checkpoint function either by employing mutant forms of spindle checkpoint proteins,
or manipulating the Mad1:Mad2 ratio. In Aim 2, I propose creating a yeast genetic system
that will allow us to select for mutations that allow cells to live when they should die when
they are forced to be aneuploid. These mutants might be informative with regard to the
types of mutations cancer cells accumulate that allow them to live when they are aneuploid.
Finally, I have identified phosphorylation sites within three subunits of the APC, a master cell
cycle regulator at metaphase that is the target of spindle checkpoint. Some of the APC
subunit phosphorylation events correlate with checkpoint activity as determined by protein
purification and mass spectroscopy. In Aim 3, I propose to perform this analysis on all APC
subunits and then to investigate the functional consequence of these phosphorylation events
both in vivo and in vitro. In combination, I suggest that the results from executing these
three Aims will contribute to a mechanistic understanding of checkpoint function that shall be
necessary for us to evaluate potential consequences on cell cycle regulation when the spindle
checkpoint is damaged in cancer cells.
Project IDs
Project ID:PA10108-0423
External Project ID:NSC101-2311-B182-001
External Project ID:NSC101-2311-B182-001
Status | Finished |
---|---|
Effective start/end date | 01/08/12 → 31/07/13 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.